Clinical pharmacokinetics and pharmacodynamics of ongericimab: A potential long‐acting PCSK9 monoclonal antibody in healthy subjects and patients with hypercholesterolemia: Randomized, double‐blind, placebo‐controlled phase Ia and Ib/II studies

Autor: Jiang, Juanjuan1 (AUTHOR), Xu, Li1 (AUTHOR), Chai, Lin1 (AUTHOR), Guan, Xiaoyuan1 (AUTHOR), Zhang, Li1 (AUTHOR), Liu, Hong1 (AUTHOR), Yan, Yan1 (AUTHOR), Li, Lili2 (AUTHOR), Zhao, Yi2 (AUTHOR), Bai, Xuelian2 (AUTHOR), Tian, Lei1 (AUTHOR) tianlei0807@163.com, Jia, Youhong3 (AUTHOR) fwjyh07@163.com
Zdroj: CTS: Clinical & Translational Science. Nov2024, Vol. 17 Issue 11, p1-13. 13p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje